Potential use of statins in reducing atrial fibrillation after off-pump coronary artery bypass grafting surgery

Circulation Journal

Volumn 74, Issue 9, 2010, Pages 1798-1799

  Muraki, Satoshi ^a   Kawaharada, Nobuyoshi ^a   Higami, Tetsuya ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; SOTALOL;

ATHEROSCLEROTIC PLAQUE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLAMMATION; OFF PUMP CORONARY SURGERY; PATHOGENESIS;

ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS, OFF-PUMP; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PREMEDICATION; PREOPERATIVE CARE;

EID: 77956106621     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0691     Document Type: Editorial

References (16)

1. Zaman AG, Archbold RA, Helft G, Paul EA, Curzen NP, Mills PG. Atrial fibrillation after coronary artery bypass surgery: A model for preoperative risk stratification. Circulation 2000; 101: 1403-1408.
2. Mathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, et al. Atrial fibrillation in coronary artery bypass grafting surgery: Predictors, outcomes, and resource utilization. JAMA 1996; 276: 300-306.
3. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720-1729.
4. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005; 79: 1530-1535.
5. Ascione R, Caputo M, Calori G, Lloyd CT, Underwood MJ, Angelini GD. Predictors of atrial fibrillation after conventional and beating heart coronary surgery: A prospective, randomized study. Circulation 2000; 102: 1530-1535.
6. Gu YJ, Mariani MA, van Oeveren W, Grandjean JG, Boonstra PW. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 1998; 65: 420-424.
7. Knayzer B, Abramov D, Natalia B, Tovbin D, Ganiel A, Katz A. Atrial fibrillation and plasma troponin I elevation after cardiac surgery: Relation to inflammation-associated parameters. J Card Surg 2007; 22: 117-123.
8. Hakala T, Pitkanen O, Hartikainen J. Cardioplegic arrest does not increase the risk of atrial fibrillation after coronary artery bypass surgery. Eur J Cardiothorac Surg 2004; 25: 415-418.
9. Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dörge H, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30,000 patients. Eur Heart J 2008; 29: 1548-1559.
10. Abuissa H, O'Keefe JH, Bybee KA. Statins as antiarrhythmics: A systematic review. Part I: Effects on risk of atrial fibrillation. Clin Cardiol 2009; 32: 544-548.
11. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia after cardiac surgery) study. Circulation 2006; 114: 1455-1461.
12. Ji Q, Mei Y, Wang X, Sun Y, Feng J, Cai J, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J 2009; 73: 2244-2249.
13. Kinoshita T, Asai T, Nishimura O, Hiramatsu N, Suzuki T, Kambara A, et al. Statin for prevention of atrial fibrillation after off-pump coronary artery bypass grafting in Japanese patients. Circ J 2010; 74: 1846-1851.
14. Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation: A meta-analysis of randomized controlled trials. J Am Coll Cardiol 2008; 51: 828-835.
15. Chen YC, Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton VP Jr, et al. Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA 2004; 291: 2821-2827.
16. Ruo B, Capra AM, Jensvold NG, Go AS. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: The Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol 2004; 43: 429-435.